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Abstract
The aim of the study was to describe the characteristics of acute hepatitis E in Greater Cairo. Patients with acute hepatitis E were iden-
tiﬁed through a surveillance of acute hepatitis using the following deﬁnition: recent (<3 weeks) onset of fever or jaundice, alanine ami-
notransferase at least three times the upper limit of normal (uln), negative markers for other causes of viral hepatitis and detectable
hepatitis E virus (HEV) RNA. Comparison of the liver tests between acute hepatitis E and hepatitis A virus (HAV), case–control analysis
(four sex-matched and age-matched (±1 year) HAV controls per case) to explore risk factors and phylogenetic analyses were per-
formed. Of the 17 acute HEV patients identiﬁed between 2002 and 2007, 14 were male. Median age was 16 years (interquartile range
13–22). Compared with HAV (n = 68 sex-matched and ±1 year age-matched), HEV patients had higher bilirubin (mean (SD) 10.9 (5.7)
uln versus 7.5 (4.4) uln, p 0.05) and aspartate aminotransferase levels (38.6 (27.1) uln versus 18.3 (18.1) uln, p 0.02). Co-infection (hepa-
titis C virus RNA or hepatitis B surface (HBs) -antigen positive/IgM anti-hepatitis B core (HBc) anitgen negative) was diagnosed in four
patients. In univariate matched analysis (17 cases, 68 matched controls), HEV cases were more likely to live in a rural area than HAV
controls (matched OR 7.9; 95% CI 2.0–30.4). Of the 16 isolates conﬁrmed as genotype 1, 15 belonged to the same cluster with 94–
98.5% identity in the open-reading frame 2 region. Our ﬁndings documented the sporadic nature of HEV in Greater Cairo, character-
ized a large number of Egyptian HEV genotype 1 strains and identiﬁed living in a rural area as a potential risk factor for infection.
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Introduction
Hepatitis E virus (HEV) is transmitted by the faecal–oral
route and is responsible for both sporadic infections and
outbreaks in developing countries with poor sanitation [1].
In these countries, the prevalence of anti-HEV IgG is high
and increases with age, reﬂecting evidence of HEV infection.
However, the overall prevalence remains lower than the
prevalence of hepatitis A virus infection (anti-HAV antibody)
and is much lower in younger age groups [1].
In rural Egypt the reported prevalence of anti-HEV anti-
body is among the highest in the world [2,3], starting early
in life with >60% of 10-year-old children having detectable
antibodies. However, compared with developing countries,
where massive outbreaks have been reported such as in
Darfur (Sudan) [4] and Uganda [5], outbreaks have not been
reported in Egypt. Furthermore, sporadic acute hepatitis
caused by HEV is uncommon [6] and none of 34 serocon-
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versions reported in a study conducted in rural Egypt were
symptomatic [7]. Isolates of HEV circulating in Egypt belong
to genotype 1 and are close to North African isolates but a
limited number of isolates have been characterized so far in
urban [8] or rural areas [6].
In this context, there is a need to further document the
public health burden of hepatitis E in Egypt, in particular, to
study the clinical impact, to describe the at-risk population,
to explore the modes of transmission, and to see how it
may differ from other enteric pathogens such as hepatitis A,
as this has implications for the control measures, including
future vaccination policies. In this paper, we describe the
main clinical and epidemiological characteristics of symptom-
atic acute hepatitis E in comparison to hepatitis A in Greater
Cairo, which comprises both rural and urban areas, and we
present the results of the phylogenetic analysis in relation to
the epidemiological characteristics.
Methods
Participants’ recruitment and questionnaire
Acute hepatitis patients were identiﬁed through a surveil-
lance system of acute hepatitis implemented in April 2002
in two fever hospitals in Cairo, Abassaia and Imbaba Fever
Hospitals. These are public hospitals specialized in infec-
tious diseases offering care to the disadvantaged population
of Greater Cairo. Until 2008, Greater Cairo included
three governorates, Cairo, El Qalyoubia and Giza, the last
two being partly rural. Details of the surveillance system
have been described elsewhere [9]. Brieﬂy, individuals
older than 5 years of age with recent (<3 weeks) fever or
jaundice, elevated serum alanine aminotransferase (ALT) at
least three times the upper limit of normal were invited
to participate. After providing written informed consent
(from one of the parents if <18 years of age), they
answered orally administered standardized questionnaires
covering socio-demographic characteristics, present and
past health conditions, and exposure to potential risk fac-
tors for viral hepatitis in the 1 to 6 months before onset
of illness.
Laboratory testing
A 10-ml venous blood sample was collected. Patients were
tested for standard liver functions (ALT, aspartate amino-
transferase (AST), bilirubin, alkaline phosphatase) and for the
following hepatitis markers: anti-HAV IgM (HAVAB, M EIA;
Abbott Laboratories, Diagnostics Division, Abbott Park, IL,
USA), HBs antigen (AUSZYME MONOCLONAL, third-gen-
eration EIA; Abbott Laboratories, Diagnostics Division) and
anti-HBc IgM (CORZYME, M rDNA; Abbott Laboratories,
Diagnostics Division). In patients with non-A non-B hepatitis,
anti-hepatitis C virus (HCV) antibody and HCV-RNA were
assessed serologically (INNOTEST HCV Ab IV; Innogenet-
ics, Ghent, Belgium) and using PCR (nested reverse transcrip-
tion PCR by in house assay using 5¢-untranslated repeat
primers). In patients with positive HCV antibodies and RNA,
exacerbation of chronic hepatitis C by other infectious agents
was ruled out using serological testing (anti-Epstein–Barr
virus (EBV) IgM (ETI-EBV-M reverse P001605; Dia Sorin, Ver-
celle, Italy), anti-cytomegalovirus (CMV) IgM
(AXSYM_system-CMV-IgM; Abbott Laboratories, Wiesba-
den, Delknheim, Germany), and anti-Toxoplasma IgM
(AXSYM system-Toxo-IgM, Abbott Laboratories)).
Real-time PCR for HEV-RNA was performed in patients with
positive HCV antibodies and RNA as well as those with
negative markers for acute hepatitis A, B and C: viral RNA
was detected in blood samples by real-time PCR with a
hydrolysis probe [10]. Serological analyses were performed
with the EIAgen HEV IgG kit and EIAgen HEV IgM kit (Adaltis
Ingen, Paris, France) as recommended by the manufacturer.
Deﬁnition of acute hepatitis E
Cases were deﬁned as follows: recent (<3 weeks) onset of
fever or jaundice, elevated serum ALT at least three times
the upper limit of normal, negative IgM anti-HAV, IgM anti-
HBc, IgM anti-EBV, CMV IgM, Toxoplasma IgM and detect-
able serum HEV RNA by reverse transcription PCR.
Phylogenetic analysis
The genotype was determined by sequencing a 189-nucleo-
tide fragment within the open reading frame 2 gene [11].
Phylogenetic trees were created by use of the neighbour-
joining method (Kimura two-parameter method). Phylo-
genetic analyses were performed with genotype information
on reference sequences based on the HEV classiﬁcation pro-
posed by Lu et al. [12].
Statistical analysis
Case–control study. For each case of hepatitis E, four acute
hepatitis A patients diagnosed at the same hospitals, in the
same year, residing in Greater Cairo and matched on age
(±1 year) and sex were randomly selected as ‘control-cases’
(HAV controls).
Laboratory ﬁndings (continuous variables) between acute
symptomatic HEV and HAV age-matched and sex matched
controls were compared using the Wilcoxon signed-rank
test. As there were four HAV controls for each HEV case,
the mean value of the four HAV controls was used to com-
pute the test.
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Matched odds ratios (mORs) and 95% CI were estimated
for each potential exposure using conditional logistic
regression to account for the matched design. Data were
analysed using STATA 10.0 software.
Ethics. Approval for the study was obtained from the Institu-
tional Review Board of the Egyptian Ministry of Population
and Health (MoPH) and the Ethics Committee of the
National Hepatology and Tropical Medicine Research Insti-
tute (NHTMRI, Egypt).
Results
Between April 2002 and December 2007, 1950 patients with
acute hepatitis were recruited from Abassaia and Imbaba
Fever Hospitals. Of these, 858, 771 and 318 were diagnosed
with acute hepatitis A, B and C, respectively.
Seventeen patients met the case deﬁnition for acute hepa-
titis E. All were positive for anti-HEV IgM and IgG. Of these,
almost two-thirds occurred in the last 4 months of each
year. Median age was 16 years (interquartile range (IQR) 13–
22) and only three were female, aged 6, 9 and 26 years,
respectively. Main clinical characteristics and laboratory
ﬁndings are presented in Table 1. All but two patients
were jaundiced and 12 presented with fever. Median serum
bilirubin was 164.2 lmol/L (IQR 121.4–218.4) and median
ALT was 1496 IU/L (IQR 848–2359). None of the patients
presented with thrombocytopenia.
Compared with hepatitis A patients (n = 858), those with
hepatitis E were slightly older (median age 12 years, IQR 8–
18 and 16 years, IQR 13–22 for hepatitis A and hepatitis E,
respectively, p 0.03) and more likely to be male (82.3%
versus 61.3%, respectively) although the latter difference
was not signiﬁcant (p 0.07). In terms of laboratory ﬁndings,
bilirubin and AST were higher in HEV than in sex-matched
and age-matched control HAV patients (Table 2).
Co-infection with HEV was diagnosed in four patients:
one tested positive for HCV RNA, anti-HCV antibody and
HBs antigen (IgM anti-HBc negative), one had a diagnosis of
acute hepatitis C (HCV RNA positive and anti-HCV antibody
negative) and two were HBs antigen positive (IgM anti-HBc
negative) (Table 4). None of these four patients presented
with clinical features of decompensation such as ascites or
hepatic encephalopathy.
Exposures
Seventeen case subjects with acute hepatitis E and 68 individ-
ually matched control subjects with acute hepatitis A were
included in the case–control study. In univariate matched
analysis, rural residency was signiﬁcantly associated with hep-
atitis E (mOR 7.9; 95% CI 2.0–30.4). HEV cases were more
likely to live in a household with more than seven occupants
and to have unsanitary toilets than HAV controls, with mOR
6.0 (95% CI 1.4–25.4) and mOR 10.2 (95% CI 1.8–46.2),
respectively. Rural residency and unsanitary toilets were
highly correlated variables. Living close to an animal shed
(inside or outside the house) had an association with hepati-
tis E but it was not signiﬁcant (mOR 2.6; 95% CI 0.6–11.9)
(Table 3).
Phylogenetic analysis
Hepatitis E virus could be sequenced in 16 of the 17 cases
and all were genotype 1. All but one of the 16 isolates
belonged to the same cluster, sharing from 94% to 98.5%
identity in the open-reading frame 2 region. The isolate that
did not belong to the cluster was close to those from the
TABLE 1. Demographic, clinical characteristics, laboratory
ﬁndings. Patients with acute hepatitis E, Greater Cairo,
April 2002–December 2007
Variable n = 17
Male sex 14 (82.3)
Age 16 (13–22)
Rural residency 8 (47.0)
Clinical manifestations
Fever 12 (70.6)
Abdominal pain 13 (76.5)
Dark urine 16 (94.1)
Scleral icterus 17 (100)
Jaundice 15 (88.2)
Laboratory ﬁndings
Total bilirubin (lmol/L) 164.2 (121.4–218.4)
Total bilirubin (· ulna) 9.7 (7.1–12.8)
Aspartate transaminase (IU/L) 1181 (720–1797)
Aspartate transaminase (· uln) 31.9 (19.4–48.6)
Alanine transaminase (IU/L) 1496 (848–2359)
Alanine transaminase (· uln) 40.4 (22.9–63.8)
Platelets (· 103)b 223.5 (172.5–357.5)
Data are numbers (%) of persons or median (inter-quartile range).
auln, upper limit of normal value.
bOne missing value.
TABLE 2. Comparison of the main clinical and laboratory
ﬁndings between acute symptomatic hepatitis E patients
and sex-matched and age-matched hepatitis A con-
trols,Greater Cairo, April 2002–December 2007
Variable
HEV cases
(n = 17)
HAV controls
(n = 68) pa
Total bilirubin (· ulnb) 9.7 (7.1–12.8) 6.9 (4.2–10.3) 0.05
Aspartate transaminase (· uln) 31.9 (19.5–48.6) 13.5 (5.1–24.9) 0.02
Alanine transaminase (· uln) 40.4 (22.9–63.8) 19.2 (14.1–41.6) 0.09
Platelets (· 103)c 223.5 (172.5–357.5) 290 (224–380) 0.12
HAV, hepatitis A virus; HEV, hepatitis E virus.
ap value of the Wilcoxon signed-rank test: 17 HEV cases, 17 HAV controls
(mean value of the four HAV controls is used). data are median (inter-quartile
range).
bTimes the upper limit of normal value.
cOne missing value in HEV cases, three missing values in HAV controls.
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Indian sub-continent and corresponded to a patient
who reported travel abroad. The 15 other isolates had
93.8–97.9% identity with the two isolates from rural central
Egypt (FJ423078-Egypt) [6] but only 89.2– 91.3% identity with
an isolate from urban Cairo (AF051352) [8] (Fig. 1). One
group of two and one group of three strains with closed
genetic identity were identiﬁed. The two individuals from the
ﬁrst group (AF00386; AF00415) were diagnosed in Novem-
ber and December 2002 and lived in the same urban district
(Table 4). Of the three individuals from the second group,
(AF01642; AF03010; AF03037), the last two were diagnosed
in September and October 2005 and lived in the same rural
district.
Discussion
The surveillance system for symptomatic acute viral hepatitis
implemented in two fever hospitals in Greater Cairo since
mid-2002 using a systematic and well-deﬁned algorithm for
the diagnosis of viral hepatitis yielded only 17 cases of acute
symptomatic HEV infection over 5 years. This system was
not meant to be exhaustive though, because it was limited
to two Cairo hospitals, restricted to symptomatic forms of
hepatitis, and used an 80% sensitive method (serum detec-
tion of HEV RNA) [13]. Its merits have been to conﬁrm the
sporadic nature of acute hepatitis E in Greater Cairo during
the study period, and would be to detect an outbreak if it
were to happen in the large catchment area of the two hos-
pitals. This study brings to light some important epidemiolog-
ical and clinical characteristics of hepatitis E in Greater
Cairo. Most patients were young, one-third of them being
<14 years of age, despite the fact that children are less likely
than young adults to present with symptoms, as documented
in HAV and hepatitis B virus (HBV) infections [14,15]. Acute
HEV infection is mostly asymptomatic. In Nepal, a country
where HEV is considered to be endemic, the proportion of
infections without symptoms estimated in the context of an
outbreak [16] or during a cohort survey [17] was 70% in
young male adults and adolescents. This ﬁnding of a young
age at infection in Greater Cairo matches earlier observa-
tions in rural areas of Egypt where >60% of children aged
over 10 years already had anti-HEV IgG [2]. Less than 1% of
acute viral hepatitis in Greater Cairo was caused by HEV.
These data conﬁrm that most HEV infections take a clinically
silent course. The majority of the patients were male, which
may reﬂect either a higher exposure, a higher susceptibility
to infection, or a higher risk of developing symptoms once
infected. In outbreaks that occurred in developing countries,
the male to female ratio is somewhat contrasted, males lar-
gely outnumbering females in some outbreaks [18] but not
in others [4,19]. Hence, a difference in exposure is a possible
hypothesis for the higher proportion of males in our study
of sporadic cases.
Regarding the biological characteristics, when compared
with HAV-infected patients, and taking into account age
(and gender), hepatitis E patients had higher values of AST
and bilirubin. These differences were not observed
between sporadic HEV and HAV infections in Europe
[20,21]. However, these HEV infections concerned much
older patients.
Infection with HEV has been recognized as a possible
cause of hepatic decompensation in patients with liver cir-
rhosis in endemic regions [22]. This was not observed in this
TABLE 3. Exposures in the 6 months before onset of symptoms in hepatitis E cases and sex-matched and age-matched hepati-
tis A controls, Greater Cairo, April 2002–December 2007
HEV cases, n (%)
(n = 17)
HAV controls, n (%)
(n = 68)
Matched OR (95% CI)
Demographic characteristics
Rural residency 8 (47.1) 7 (10.3) 7.9 (2.0–30.4)
Travel outside Egypt 1 0 –
Travel in Egypt 3 (17.6) 10 (14.7) 1.3 (0.3–6.8)
Number of persons in the house >7a 5 (29.4) 4 (6.0) 6.0 (1.4–25.4)
Ratio of household occupants to sleeping rooms >4a 3 (17.7) 4 (6.0) 3.0 (0.7–13.4)
Contact with a jaundiced personb 0 6 (9.2) –
Sanitation
Water outside the house 0 1 –
Unsanitary toiletsc 7 (41.2) 6 (8.8) 10.2 (1.8–46.2)
Consumption of unwashed vegetables 12 (70.6) 42 (61.8) 1.7 (0.4–6.8)
Contact with animals
Any contact at home or work 4 (23.5) 9 (13.2) 2.2 (0.5–9.6)
Animal shed (inside or outside the house versus none) 3 (17.6) 5 (7.3) 2.6 (0.6–11.9)
Rats a nuisance in the house 6 (35.3) 19 (28.4) 1.3 (0.5–3.9)
HAV, hepatitis A virus; HEV, hepatitis E virus.
aOne missing value among HAV controls.
bContact with a jaundiced person: three missing values in HAV controls; one in HEV cases.
cToilets with no built-in ﬂushing mechanism.
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study, despite four patients having co-infection with HBV or
HCV. However, these patients were too young to have
already developed a severe liver disease as the result of
HCV or HBV infection and one of them had an acute HCV
infection. It is of interest that the prevalence of chronic
HCV infection (1/17) among hepatitis E patients was not dif-
ferent from that expected among young adults of Greater
Cairo [23]. It would suggest that chronic HCV infection does
not greatly predispose to symptomatic forms of acute hepati-
tis E. This may not be the case for chronic HBV infection,
whose prevalence (3/17) in this group exceeded the 5%
expected among young adults of Greater Cairo. One
woman, aged 26 years, had evidence of acute HCV infection
(positive HCV RNA without HCV antibodies) following a
caesarean section without any blood transfusion reported.
The simultaneous occurrence of acute HCV and HEV infec-
tions, despite different modes of transmission (although cases
of hepatitis E after blood transfusions have been reported
[24]), is surprising.
Living in a rural area was associated with a higher risk of
hepatitis E. This, together with the absence of waterborne
outbreaks reported in Egypt, would indicate contamination
from domestic animals raised in close proximity to or within
the household. However, contact with animals was not sig-
niﬁcantly associated with hepatitis E. Stoszek et al. [7] found
positive anti-HEV but no HEV genome in domestic animals
and rodents in the two villages (Nile delta and upper Egypt)
where they conducted a sero-incidence survey among the
residents, and HEV genotype 1 has been detected in work
horses in old Cairo [25]. However, a zoonotic reservoir and
(a) (b)
FIG. 1. Phylogenetic tree of hepatitis E virus (HEV) isolates recovered in Greater Cairo, April 2002 to December 2007. Phylogenetic tree con-
structed by neighbour-joining based on the open-reading frame 2 region of the HEV genome, 189 nucleotides (a) or 97 nucleotides (b). The phy-
logenetic analysis includes HEV sequences recovered from Egyptian patients (sequence names are highlighted in grey for the patients of this
study) and GenBank reference sequences. HEV sequence names are labelled as follows: name of the sequence, genotype, country of origin and
host.
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evidence for possible transmission have been documented
only for HEV genotype 3 in Europe and genotype 4 in Japan
[26]. In developing countries where outbreaks occurred,
they were related to consumption of faecally contaminated
drinking water. All the 17 patients in this study had access to
water inside their houses. According to the 2008 Egyptian
Demographic Health Survey, 90.0%/97.4% of the households
in rural/urban areas in lower Egypt have access to water
piped into the residence [23]. However, access to water
from the tap in the dwelling may not prevent episodes of
contamination of the water in cases of leaky water pipes
passing through soil that is contaminated with sewage [27].
Although episodes of water contamination can provoke out-
breaks, they may not be a common cause for sporadic cases.
Groups of strains with closed genetic identity clustered in
time and place (same district) observed in this study may
support common exposures, among which sporadic contami-
nation of water is a possibility.
The proportion of individuals living in a household with a
high number of occupants was signiﬁcantly higher in patients
infected with HEV than in HAV controls. This may reﬂect
poor living conditions and the potential for person-to-person
transmission. However, in contrast to HAV [14], the role of
person-to-person transmission of HEV, either in epidemic or
in sporadic context, is still debated [28–30].
This study has several limitations. As a result of the lim-
ited sample size for the case–control analysis, we could not
perform a multivariable analysis. Because of the nature of the
comparison group (HAV cases), associations between expo-
sures and acute hepatitis E should be interpreted with cau-
tion. Environmental exposures were not fully explored
through the questionnaire.
The present work has characterized a large number of
Egyptian HEV strains. Our data indicate that the majority
belong to an unclassiﬁed subtype, different from the one
described by Tsarev et al. [8] and classiﬁed as subtype 1e by
Lu et al. [12]. Until recently, only genotype 1 strains were
found in Egypt in humans [6,8] or in animals [25]. Surpris-
ingly, a genotype 3 virus was recently identiﬁed in the stools
of a child with acute hepatitis [31].
In conclusion, this study documented the sporadic nature
of acute symptomatic hepatitis E in greater Cairo and the
TABLE 4: Characteristics and selected exposures of the 16 patients with acute hepatitis E included in the phylogenetic analy-
sis, Greater Cairo, April 2002-December 2007
Sequence
id
Year
Month
Age
years Sex Co-infection ALT rural
Contact
animals
Travel
outside
Egypt Other & comments
AF00268 2002
Aug
16 M No 2646 Yes Yes No
AF00205 2002
Aug
14 M No 848 Yes Yes No
AF00271 2002
Sep
16 M No 2513 Yes No No
AF00386 2002
Nov 4
22 M HBs antigen positive 1496 No Yes No Natural herb consumption
for medical purpose
Same district as AF00415
AF00415 2002
Dec 8
20 M No 1596 No No No Same district as
AF00386
AF00934 2003
June
24 M HBs antigen positive
HCV EIA, &PCR positive
5300 No No No Tooth extraction +anesthesia
Same governorate as AF01320 and
districts next to each other
AF01102 2003
Sep
9 F No 1777 No No No
AF01298 2003
Sep
9 M No 903 No No No
AF01320 2003
Oct
6 M No 625 Yes Yes No Same governorate as AF00934
and districts next to each other
AF01642 2004
Jan
26 F HCV PCR positive, HCV
EIA negative
500 No No No Cesarean section. IV injections
AF01738 2004
Feb
21 M HBs antigen positive 2359 Yes Yes No
AF02383 2004
Sep
14 M No 2356 No No No
AF02510 2005
Feb
35 M No 750 No No No
AF03010 2005
Sept 18
13 M No 3199 Yes No No Same city/district as AF03037
AF03037 2005
Oct 30
19 M No 442 Yes No No Same city/district as AF03010
AF5017 2007
Nov
22 M No 1390 No No Yes
ALT, aminotransferase (IU/L); EIA, enzyme immunoassay; HBs, hepatitis B surface; HCV, hepatitis C virus.
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early exposure to HEV in life. Serious clinical disease seems
to be rare. Our ﬁndings suggest the potential role of living in
rural areas as a risk factor for HEV infection which deserves
to be further explored in studies including an in-depth envi-
ronmental investigation and combined virological investiga-
tions to identify the source of the different HEV strains
circulating in Egypt.
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